ProPhase Labs, Inc. Interest Expense
ProPhase Labs, Inc. (PRPH) reported Interest Expense of $515.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-10
- ProPhase Labs, Inc. interest expense for the quarter ending 2024-03-31 was $515.00K, a 139.53% increase year-over-year.
- ProPhase Labs, Inc. interest expense for the quarter ending 2023-12-31 was $494.00K, a 282.95% increase year-over-year.
- ProPhase Labs, Inc. interest expense for the quarter ending 2023-09-30 was $275.00K, a 36.82% increase year-over-year.
- ProPhase Labs, Inc. interest expense for the quarter ending 2023-06-30 was $291.00K, a 44.78% increase year-over-year.
- ProPhase Labs, Inc. interest expense for fiscal 2023 was $1.27M, a 66.88% increase from fiscal 2022.
- ProPhase Labs, Inc. interest expense for fiscal 2022 was $764.00K, a 33.45% decline from fiscal 2021.
- ProPhase Labs, Inc. interest expense for fiscal 2021 was $1.15M, a 289.15% increase from fiscal 2020.
- ProPhase Labs, Inc. interest expense for fiscal 2020 was $295.00K.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2024-03-31 | $515.00K 10-Q · filed 2024-05-10 | $1.01M derived: sum of 2 quarters · filed 2024-05-10 | $1.28M derived: sum of 3 quarters · filed 2024-05-10 | $1.57M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2023-12-31 | $494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $769.00K derived: sum of 2 quarters · filed 2024-03-29 | $1.06M derived: sum of 3 quarters · filed 2024-03-29 | $1.27M 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $275.00K 10-Q · filed 2023-11-13 | $566.00K derived: sum of 2 quarters · filed 2023-11-13 | $781.00K 10-Q · filed 2023-11-13 | $910.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2023-06-30 | $291.00K 10-Q · filed 2023-08-11 | $506.00K 10-Q · filed 2023-08-11 | $635.00K derived: sum of 3 quarters · filed 2024-05-10 | $836.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2023-03-31 | $215.00K 10-Q · filed 2024-05-10 | $344.00K derived: sum of 2 quarters · filed 2024-05-10 | $545.00K derived: sum of 3 quarters · filed 2024-05-10 | $746.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $330.00K derived: sum of 2 quarters · filed 2024-03-29 | $531.00K derived: sum of 3 quarters · filed 2024-03-29 | $764.00K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $201.00K 10-Q · filed 2023-11-13 | $402.00K derived: sum of 2 quarters · filed 2023-11-13 | $635.00K 10-Q · filed 2023-11-13 | $913.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $201.00K 10-Q · filed 2023-08-11 | $434.00K 10-Q · filed 2023-08-11 | $712.00K derived: sum of 3 quarters · filed 2023-08-11 | $1.01M derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $233.00K 10-Q · filed 2023-05-12 | $511.00K derived: sum of 2 quarters · filed 2023-05-12 | $807.00K derived: sum of 3 quarters · filed 2023-05-12 | $1.13M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $574.00K derived: sum of 2 quarters · filed 2023-03-29 | $897.00K derived: sum of 3 quarters · filed 2023-03-29 | $1.15M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $296.00K 10-Q · filed 2022-11-10 | $619.00K derived: sum of 2 quarters · filed 2022-11-10 | $870.00K 10-Q · filed 2022-11-10 | $1.12M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $323.00K 10-Q · filed 2022-08-12 | $574.00K 10-Q · filed 2022-08-12 | $828.00K derived: sum of 3 quarters · filed 2022-08-12 | $869.00K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $251.00K 10-Q · filed 2022-05-13 | $505.00K derived: sum of 2 quarters · filed 2022-05-13 | $546.00K derived: sum of 3 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $295.00K derived: sum of 2 quarters · filed 2022-03-31 | $295.00K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $41.00K 10-Q · filed 2021-11-12 | $41.00K 10-Q · filed 2021-11-12 | |||||
| 2017-12-31 | $54.00K 10-K/A · filed 2018-08-20 | ||||||
| 2017-03-31 | $54.00K 10-Q/A · filed 2018-08-20 | $109.00K derived: sum of 2 quarters · filed 2018-08-20 | $162.00K derived: sum of 3 quarters · filed 2018-08-20 | $215.00K derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2016-12-31 | $55.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $108.00K derived: sum of 2 quarters · filed 2018-08-20 | $161.00K derived: sum of 3 quarters · filed 2018-08-20 | $213.00K 10-K/A · filed 2018-08-20 | |||
| 2016-09-30 | $53.00K 10-Q · filed 2016-11-14 | $106.00K derived: sum of 2 quarters · filed 2016-11-14 | $158.00K 10-Q · filed 2016-11-14 | $173.00K derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2016-06-30 | $53.00K 10-Q · filed 2016-08-11 | $105.00K 10-Q · filed 2016-08-11 | $120.00K derived: sum of 3 quarters · filed 2018-08-20 | $121.00K derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2016-03-31 | $52.00K 10-Q/A · filed 2018-08-20 | $67.00K derived: sum of 2 quarters · filed 2018-08-20 | $68.00K derived: sum of 3 quarters · filed 2018-08-20 | $68.00K derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2015-12-31 | $15.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $16.00K derived: sum of 2 quarters · filed 2018-08-20 | $16.00K derived: sum of 3 quarters · filed 2018-08-20 | $18.00K 10-K/A · filed 2018-08-20 | |||
| 2015-09-30 | $1.00K 10-Q · filed 2016-11-14 | $1.00K derived: sum of 2 quarters · filed 2016-11-14 | $3.00K 10-Q · filed 2016-11-14 | $8.00K derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.00K 10-Q · filed 2016-08-11 | $7.00K derived: sum of 3 quarters · filed 2017-02-24 | $8.00K derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-13 | $7.00K derived: sum of 2 quarters · filed 2017-02-24 | $8.00K derived: sum of 3 quarters · filed 2017-02-24 | $9.00K derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $7.00K derived: sum of 2 quarters · filed 2017-02-24 | $8.00K derived: sum of 3 quarters · filed 2017-02-24 | $10.00K 10-K · filed 2017-02-24 | |||
| 2014-09-30 | $1.00K 10-Q · filed 2015-11-13 | $2.00K 10-Q · filed 2014-11-13 | $2.00K derived: sum of 2 quarters · filed 2015-11-13 | $4.00K 10-Q · filed 2015-11-13 | $7.00K 10-Q · filed 2014-11-13 | $8.00K derived: sum of 4 quarters · filed 2016-03-29 | |
| 2014-06-30 | $1.00K 10-Q · filed 2015-08-12 | $2.00K 10-Q · filed 2014-08-12 | $3.00K 10-Q · filed 2015-08-12 | $4.00K 10-Q · filed 2014-08-12 | $7.00K derived: sum of 3 quarters · filed 2016-03-29 | $10.00K derived: sum of 4 quarters · filed 2016-03-29 | |
| 2014-03-31 | $2.00K 10-Q · filed 2015-05-13 | $6.00K derived: sum of 2 quarters · filed 2016-03-29 | $9.00K derived: sum of 3 quarters · filed 2016-03-29 | $11.00K derived: sum of 4 quarters · filed 2016-03-29 | |||
| 2013-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $7.00K derived: sum of 2 quarters · filed 2016-03-29 | $9.00K derived: sum of 3 quarters · filed 2016-03-29 | $13.00K 10-K · filed 2016-03-29 | |||
| 2013-09-30 | $3.00K 10-Q · filed 2014-11-13 | $5.00K derived: sum of 2 quarters · filed 2014-11-13 | $9.00K 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | $2.00K 10-Q · filed 2014-08-12 | $5.00K 10-Q · filed 2014-08-12 | |||||
| 2013-03-31 | $3.00K 10-Q · filed 2014-05-12 | ||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-27 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |